Mar 3, 2026 08:00AM
Feb 26, 2026 06:00AM
Oct 30, 2025 04:16PM
Oct 30, 2025 04:15PM
Oct 20, 2025 08:00AM
Sep 4, 2025 08:00AM
Jul 3, 2025 07:39AM Morgan Stanley Assumes Certara Inc. (CERT) at Equalweight
May 8, 2025 06:03AM
May 5, 2025 04:15PM
Apr 14, 2025 08:16AM
Apr 14, 2025 08:15AM
Apr 1, 2025 08:00AM
Apr 1, 2025 08:00AM
Apr 1, 2025 08:00AM Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
Dec 2, 2024 04:15PM
Sep 24, 2024 08:00AM
Sep 18, 2024 08:00AM
Sep 18, 2024 08:00AM
Aug 15, 2024 04:15PM
Aug 15, 2024 04:15PM
Nov 21, 2023 04:30PM Certara, Inc. (CERT) Introduces Simcyp Biopharmaceutics Software
Nov 21, 2023 04:30PM
Nov 21, 2023 04:30PM
Sep 19, 2023 08:15AM
Aug 29, 2023 08:15AM
Aug 29, 2023 08:15AM
Aug 3, 2023 09:00PM
Apr 27, 2023 08:00AM Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
Apr 27, 2023 08:00AM
Mar 21, 2023 08:00AM
Mar 7, 2023 08:00AM
Mar 7, 2023 08:00AM
Aug 5, 2022 08:00AM
Aug 5, 2022 08:00AM
Jun 28, 2022 08:00AM Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development
Jun 28, 2022 08:00AM
Jun 21, 2022 08:00AM
Feb 23, 2022 04:31PM
Feb 23, 2022 04:30PM
Feb 23, 2022 04:30PM
Feb 15, 2022 04:30PM
Feb 15, 2022 04:30PM Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
Dec 21, 2021 08:02AM
Dec 21, 2021 08:00AM
Dec 21, 2021 08:00AM
Dec 13, 2021 08:00AM
Dec 13, 2021 08:00AM
Dec 2, 2021 08:00AM
Dec 2, 2021 08:00AM Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances
Oct 28, 2021 08:02AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All